A five-inch, battery-operated black box could be the future of tuberculosis diagnosis. The device, developed this year by a team of Texas doctors, can spot tiny amounts of TB bacteria in coughed-out sputum samples in less than half an hour. That’s a fraction of the time it takes to diagnose the disease using the most common methods today.
The device, to be marketed under the name TB REaD, is “designed to be really simple and require no technical experience,” said Jeffrey Cirillo, a professor at the Texas A&M Health Science Center College of Medicine who led the product’s development. “We want this to be able to be used anywhere.”
Cirillo’s work – supported by a partnership that includes the Foundation for Innovative New Diagnostics (FIND), the Wellcome Trust, the National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation – is just one example of the kind of innovation made possible by collaborations among non-government organizations, private companies and government bodies in the fight against TB.